Prognostic factors and outcomes of adult spermatic cord sarcoma. A study from the French Sarcoma Group
Gilles Achard(Centre Georges François Leclerc), Nicolás Isambert(Centre Georges François Leclerc), Dimitri Tzanis(Université Paris Cité), Sophie Le Guellec(Centre National de la Recherche Scientifique), Céline Charon‐Barra(Centre Georges François Leclerc), Sylvie Bonvalot(Dana-Farber Cancer Institute), François Le Loarer(Institut Bergonié), Charles Honoré(Institut Gustave Roussy), Sylvain Causeret(Champalimaud Foundation), Pierre Méeus(Centre Léon Bérard), Aurélie Bertaut(Institut de Cancérologie de Bourgogne), Marie Karanian(Physiopathologie, diagnostic et traitements des maladies musculo-squelettiques), Sébastien Carrère, Carine Ngo(Institut Gustave Roussy), Magali Fau(University of Toronto), Jean‐Baptiste Delhorme(Hôpitaux Universitaires de Strasbourg)
Cited by 6
Related Papers
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
|Annals of Oncology|2021|978